Medroxyprogesterone Acetate | GMP-Certified USP/EP Grade Hormone API? ??
Contraceptive & Oncology Applications with ≥99% Purity

?? ?Product Overview?

Medroxyprogesterone Acetate is a synthetic progestin widely used in hormonal contraceptives, oncology therapies, and hormone replacement treatments?12. It regulates progesterone receptors to inhibit ovulation and suppress estrogen-dependent tumor growth?14. Suitable for ?oral tablets?, ?injectables?, and ?implantable devices?, it meets ?pharmaceutical-grade? standards for precision and safety?12.

? ?Key Advantages?

?? ?Applications?

1. ?Contraceptives?

   : Long-acting injectables (e.g., Depo-Provera?) and oral formulations?14.

2. ?Oncology?

   : Adjunctive therapy for endometrial and renal cancers?24.

3. ?Gynecological Disorders?

   : Treatment of endometriosis and abnormal uterine bleeding?12.

4. ?Hormone Replacement Therapy (HRT)?

   : Menopause symptom management?14.

?? ?Quality Certifications?

• Manufactured under ?GMP?, ?ISO 9001?, and ?WHO? guidelines? .

• Tested via HPLC?, ?GC-MS?, and ?residual solvent analysis?.

• Compliant with ?FDA 21 CFR?and ?EU GMP Annex 1?.

?? ?Market Trends?

The global hormonal contraceptives market is projected to reach ?$23.7B by 2030?, driven by rising demand for long-acting reversible contraceptives?24. Oncology applications of progestins are growing at ?6.8% CAGR?, supported by advancements in targeted cancer therapies?14.